MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.201703-0603oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2017

Effect of Obstructive Sleep Apnea Treatment on Renal Function in Patients with Cardiovascular Disease.

Loffler Kelly A, Heeley Emma, Freed Ruth, Anderson Craig S, Brockway Ben, Corbett Alastair, Chang Catherina L, Douglas James A, Ferrier Katherine, Graham Neil, Hamilton Garun S, Hlavac Michael, McArdle Nigel, McLachlan John, Mukherjee Sutapa, Naughton Matthew T, Thien Francis, Young Alan, Grunstein Ronald R, Palmer Lyle J, Woodman Richard J, Hanly Patrick J, McEvoy R Doug, SAVE (Sleep Apnea Cardiovascular Endpoints) Investigators

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

RATIONALE: Obstructive sleep apnea (OSA) is associated with impaired renal function, but uncertainty exists over whether OSA treatment can influence renal outcomes.

OBJECTIVES

To determine the effects of continuous positive airway pressure (CPAP) on renal function in subjects with coexisting OSA and cardiovascular disease.

METHODS

This was a substudy of the international SAVE (Sleep Apnea Cardiovascular Endpoints) trial, in which 2,717 patients with moderate to severe OSA and established coronary or cerebrovascular disease were randomized to receive either CPAP plus usual care or usual care alone. Renal function and adverse renal events were compared between the CPAP (n = 102) and usual care (n = 98) groups. Glomerular filtration rate was estimated at randomization and at the end of follow-up, and the urinary albumin-to-creatinine ratio was measured at study exit.

MEASUREMENTS AND MAIN

RESULTS

In 200 substudy participants (mean age, 64 yr; median, 4% oxygen desaturation index; 20 events/h; mean estimated glomerular filtration rate at baseline, 82 ml/min/1.73 m2), the median (interquartile range) changes in estimated glomerular filtration rate (ml/min/1.73 m2/yr) were -1.64 (-3.45 to -0.740) in the CPAP group and -2.30 (-4.53 to -0.71) in the usual care group (P = 0.21) after a median of 4.4 years. There were no between-group differences in end-of-study urinary albumin-to-creatinine ratio or in the occurrence of serious renal or urinary adverse events during the trial. The level of CPAP adherence did not influence the findings.

CONCLUSIONS

CPAP treatment of OSA in patients with cardiovascular disease does not alter renal function or the occurrence of renal adverse events. Clinical trial registered with www.clinicaltrials.gov (NCT00738179).

Для цитирования: Loffler Kelly A, Heeley Emma, Freed Ruth, Anderson Craig S, Brockway Ben, Corbett Alastair, Chang Catherina L, Douglas James A, Ferrier Katherine, Graham Neil, Hamilton Garun S, Hlavac Michael, McArdle Nigel, McLachlan John, Mukherjee Sutapa, Naughton Matthew T, Thien Francis, Young Alan, Grunstein Ronald R, Palmer Lyle J, Woodman Richard J, Hanly Patrick J, McEvoy R Doug, SAVE (Sleep Apnea Cardiovascular Endpoints) Investigators. Effect of Obstructive Sleep Apnea Treatment on Renal Function in Patients with Cardiovascular Disease.. American journal of respiratory and critical care medicine. 2017. DOI: 10.1164/rccm.201703-0603oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.